These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14634494)

  • 1. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.
    Petrakis IL; Leslie D; Rosenheck R
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1780-4. PubMed ID: 14634494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
    Iheanacho T; Issa M; Marienfeld C; Rosenheck R
    Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do patients with alcohol dependence use more services? A comparative analysis with other chronic disorders.
    Fortney JC; Booth BM; Curran GM
    Alcohol Clin Exp Res; 1999 Jan; 23(1):127-33. PubMed ID: 10029213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of nursing home admission in association with mental illness nationally in the Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Med Care; 2006 Apr; 44(4):343-51. PubMed ID: 16565635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antidepressants in alcohol-dependent veterans.
    Petrakis IL; Leslie D; Rosenheck R
    J Clin Psychiatry; 2003 Aug; 64(8):865-70. PubMed ID: 12926999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs.
    Harpaz-Rotem I; Rosenheck RA
    Arch Gen Psychiatry; 2009 Apr; 66(4):417-21. PubMed ID: 19349311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
    Fisher DA; Galanko J; Dudley TK; Shaheen NJ
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration.
    Mohamed S; Rosenheck R
    Am J Geriatr Psychiatry; 2008 Oct; 16(10):804-12. PubMed ID: 18827226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hysterectomy and associated factors in women Veterans Affairs patients.
    Gardella C; Johnson KM; Dobie DJ; Bradley KA
    J Reprod Med; 2005 Mar; 50(3):166-72. PubMed ID: 15841928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental illness and use of home care nationally in the U.S. Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1046-56. PubMed ID: 18056823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of childhood abuse on the course of bipolar disorder: a replication study in U.S. veterans.
    Brown GR; McBride L; Bauer MS; Williford WO;
    J Affect Disord; 2005 Dec; 89(1-3):57-67. PubMed ID: 16213029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program.
    Lockwood A; Steinke DT; Botts SR
    Ann Pharmacother; 2009 Jul; 43(7):1227-32. PubMed ID: 19584387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Naltrexone use in the treatment of alcoholism in Spain].
    Rubio Valladolid G; Espí Martínez F; Sanchís Fortea M; Bravo García De Laguna JL
    Rev Clin Esp; 2002 Aug; 202(8):435-9. PubMed ID: 12199993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.